Updated Jun 25, 2026

Selected portfolio

Top 1 · Quarterly · Top-Rated

Rank #47

Risk

Experimental

Stocks included

Top 1

Rebalance

Quarterly

Weighting

Equal weight

Key metrics

Since Feb 17, 2026

  • Total return

    +15.4%
  • Performance vs S&P 500

    +7.9%
  • Sharpe ratio

    0.97
  • CAGR

    +50.5%
  • Max drawdown

    -17.0%

What you are looking at

Starting capital: $10,000 simulated. Disclaimer

#StockAllocationReturn

Returns

Risk

Consistency

Want the methodology notes?

See the full methodology, portfolio-ranking rules, and scientific grounding.

Not investment advice. Past performance does not guarantee future results. Full disclaimer